HMGCR and metabolic dysfunction-associated steatotic liver disease: TSH can directly increase hepatic gluconeogenesis, repress hepatic bile acid synthesis, and cause hypercholesterolemia by decreasing HMG-CoA reductase phosphorylation (63–65), which further leads to the development of NAFLD.